Clinical Trials at BUP CPF
During the past decade, BUP CPF conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at BUP CPF
According to Clinical.Site data, the most researched conditions in "BUP CPF" are
"Anxiety Disorders" (1 trials), "Behavior Problem" (1 trials), "Obsessive-Compulsive Disorder" (1 trials), "Parenting" (1 trials) and "Persistent (Chronic) Motor or Vocal Tic Disorder" (1 trials). Many other conditions were trialed in "BUP CPF" in a lesser frequency.
Clinical Trials Intervention Types at BUP CPF
Most popular intervention types in "BUP CPF" are "Behavioral" (5 trials). Other intervention types were less common.
The name of intervention was led by "BIP SAMBA" (1 trials), "Group-therapy + ICBT" (1 trials), "Internet-based CBT" (1 trials), "Internet-delivered Cognitive Behavioral Therapy" (1 trials) and "Internet-delivered exposure and response prevention" (1 trials). Other intervention names were less common.
Clinical Trials Genders at BUP CPF
The vast majority of trials in "BUP CPF" are
5 trials for "All" genders.
Clinical Trials Status at BUP CPF
Currently, there are NaN active trials in "BUP CPF".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in BUP CPF,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in BUP CPF, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".